Literature DB >> 9645469

Metabolism of 8-iso-prostaglandin F2alpha.

S Basu1.   

Abstract

Tritium labelled (x=1.1 MBq/17.7 microg/kg) and unlabelled 8-iso-PGF2alpha (43 microg/kg) were administered intravenously to female rabbits and frequent blood and continuous urinary samples were collected up to 4 h. The total radioactivity was lost rapidly from the circulation. About 80% of the total radioactivity was found in urine within 4 h. The plasma half-life of 8-iso-PGF2alpha is found to be 1 min at the distribution phase. The terminal elimination phase half-life was about 4 min. At 1.5 min after administration 64%, 19% and 13% of the plasma radioactivity represented 8-iso-PGF2alpha, 15-keto-8-iso-PGF2alpha and beta-oxidised products, respectively. The values for 20-min plasma were 5%, 2%, and 88%. The radiochromatograms from 10 min-4 h urinary samples were dominated by more polar beta-oxidised products. Alpha-Tetranor-15-keto-13,14-dihydro-8-iso-PGF2alpha was identified as a major urinary metabolite.Thus, 8-iso-PGF2alpha metabolises in the rabbit mainly to several degraded polar metabolites through dehydrogenation at C-15, reduction of delta13-double bond and beta-oxidation, and excretes efficiently into the urine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645469     DOI: 10.1016/s0014-5793(98)00481-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  Metabolic syndrome, aging and involvement of oxidative stress.

Authors:  Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

2.  Effect of Cruciferous Vegetable Intake on Oxidative Stress Biomarkers: Differences by Breast Cancer Status.

Authors:  Michael D Wirth; E Angela Murphy; Thomas G Hurley; James R Hébert
Journal:  Cancer Invest       Date:  2017-03-08       Impact factor: 2.176

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

4.  Prenatal phthalate exposure and 8-isoprostane among Mexican-American children with high prevalence of obesity.

Authors:  V Tran; G Tindula; K Huen; A Bradman; K Harley; K Kogut; A M Calafat; B Nguyen; K Parra; X Ye; B Eskenazi; N Holland
Journal:  J Dev Orig Health Dis       Date:  2016-12-29       Impact factor: 2.401

Review 5.  Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?

Authors:  Harold J Ting; Fadi T Khasawneh
Journal:  J Biomed Sci       Date:  2010-04-06       Impact factor: 8.410

6.  Physiological response to lipid peroxidation in ischemia and reperfusion during carotid endarterectomy.

Authors:  Sebastiano Banni; Roberto Montisci; Roberto Sanfilippo; Gabriele Finco; Daniela Sanna; Elena Giordano; Elisabetta Murru; Lina Cordeddu; Gianfranca Carta; Donata Banni; Antonio Marchi
Journal:  Lipids Health Dis       Date:  2010-04-21       Impact factor: 3.876

7.  F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review.

Authors:  Subramanian Kaviarasan; Sekaran Muniandy; Rajes Qvist; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

8.  Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy.

Authors:  L Monnier; C Colette; E Mas; F Michel; J P Cristol; C Boegner; D R Owens
Journal:  Diabetologia       Date:  2009-11-05       Impact factor: 10.122

9.  Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Habibul Ahsan; Wei-Yann Tsai; Li-Yu Wang; Shu-Yuan Chen; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

Review 10.  Isoprostanes: more than just mere markers.

Authors:  D J Crankshaw; P K Rangachari
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.